Literature DB >> 15095291

Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice.

S Marchetti1, C Gimond, D Roux, E Gothié, J Pouysségur, Gilles Pagès.   

Abstract

The p42/p44 mitogen activated protein kinase (MAPK) pathway participates in a wide range of cellular programs including proliferation, migration, differentiation, and survival. Specific pharmacological inhibitors, like PD98059 and U0126, are often used to inhibit p42/p44 MAPK signaling. However, these inhibitors are not appropriate to study the function of these kinases in whole organisms. We thus developed an inducible system designed to inhibit p42/p44 MAPK activity through the expression of a phosphatase specific for these two kinases, the MAPK phosphatase 3 (MKP-3). A fibroblast cell line was established in which MKP-3 expression is controlled by tetracycline. Tetracycline-induced MKP-3 resulted in partial de-phosphorylation of p42/p44 MAPKs in serum-stimulated cells. However, we could improve MKP-3 stability and thereby the rate of MAPK de-phosphorylation, when the C-terminal end of MKP-3 was fused to the green fluorescent protein (GFP). Importantly, the fusion of GFP to MKP-3 did not alter the specificity of the phosphatase towards its MAPK substrates. We further show that conditional expression of MKP-3-GFP in this fibroblast cell line results in the inhibition of: (a) the phosphorylation of the p42/p44 MAPK substrates Elk1 and HIF-1alpha, (b) vascular endothelial growth factor (VEGF), cyclin D1, and c-fos gene transcription in response to MAPK pathway activation, and (c) cell proliferation. Finally, the MKP-3-GFP inducible cell line was transformed by Ha-ras and injected into nude mice. Treatment of mice with the tetracycline analog doxycycline resulted in a large delay in tumor emergence and growth as compared to the untreated control group, indicating that MKP-3-GFP activity is maintained in vivo. Altogether, these results show that inducible expression of MKP-3-GFP constitutes a valuable tool to study the role of p42/p44 MAPKs in various cellular responses in both cultured cell and animal models, a tool that may also be used to block unwanted cell growth in pathological conditions. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15095291     DOI: 10.1002/jcp.10465

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

Review 1.  Modulation of protein kinase signaling cascades by palytoxin.

Authors:  Elizabeth V Wattenberg
Journal:  Toxicon       Date:  2010-11-09       Impact factor: 3.033

2.  Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer.

Authors:  C Vanesa Díaz-García; Alba Agudo-López; Carlos Pérez; Elena Prieto-García; Lara Iglesias; Santiago Ponce; Analia Rodríguez Garzotto; José L Rodríguez-Peralto; Hernán Cortés-Funes; José A López-Martín; M Teresa Agulló-Ortuño
Journal:  Tumour Biol       Date:  2014-10-25

Review 3.  Palytoxin: exploiting a novel skin tumor promoter to explore signal transduction and carcinogenesis.

Authors:  Elizabeth V Wattenberg
Journal:  Am J Physiol Cell Physiol       Date:  2006-07-19       Impact factor: 4.249

4.  Extracellular signal-regulated kinases phosphorylate mitogen-activated protein kinase phosphatase 3/DUSP6 at serines 159 and 197, two sites critical for its proteasomal degradation.

Authors:  Sandrine Marchetti; Clotilde Gimond; Jean-Claude Chambard; Thomas Touboul; Danièle Roux; Jacques Pouysségur; Gilles Pagès
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

5.  Dual role of Sp3 transcription factor as an inducer of apoptosis and a marker of tumour aggressiveness.

Authors:  Khadija Essafi-Benkhadir; Sébastien Grosso; Alexandre Puissant; Guillaume Robert; Makram Essafi; Marcel Deckert; Emmanuel Chamorey; Olivier Dassonville; Gérard Milano; Patrick Auberger; Gilles Pagès
Journal:  PLoS One       Date:  2009-02-12       Impact factor: 3.240

6.  WT1 induction of mitogen-activated protein kinase phosphatase 3 represents a novel mechanism of growth suppression.

Authors:  Debra J Morrison; Marianne K H Kim; Windy Berkofsky-Fessler; Jonathan D Licht
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

7.  Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells.

Authors:  Zhenfeng Zhang; Susumu Kobayashi; Alain C Borczuk; Rom S Leidner; Thomas Laframboise; Alan D Levine; Balazs Halmos
Journal:  Carcinogenesis       Date:  2010-01-22       Impact factor: 4.741

Review 8.  The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs).

Authors:  Andrew M Kidger; Stephen M Keyse
Journal:  Semin Cell Dev Biol       Date:  2016-01-11       Impact factor: 7.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.